SpaceX now says potential blockbuster Tesla merger would need Elon Musk's approval

SpaceX said any potential combination with Tesla requires approval from its special committee, board and controlling shareholder Elon Musk; no decision has been made. The potential merger has been discussed at a $3.5 trillion valuation, but Musk’s endorsement has raised concerns about conflicts of interest and shareholder scrutiny. Tesla cut its annual capex forecast to roughly $20 billion from more than $25 billion, while SpaceX expects $35 billion-$40 billion of capex in the fourth quarter; SpaceX shares rose about 1% and Tesla shares fell marginally in extended trading.

Analysis

The key risk is not whether the businesses can share engineering or AI infrastructure; it is who controls the combined capital budget and on what terms. Tesla shareholders could bear financing or dilution costs for SpaceX priorities without equivalent governance rights or demonstrable returns. The capex divergence makes this more than a theoretical concern: a combination would pool competing calls on capital, not create incremental cash automatically.

Musk’s approval requirement, combined with his influence on both sides, raises the probability of a prolonged process and a governance discount for Tesla. A special committee and board process may constrain terms or timing, but does not itself resolve the perceived conflict. SpaceX’s defense and intelligence exposure alongside Tesla’s China operating footprint also creates a potential national-security and regulatory complication for a combined entity; that is a risk to diligence, not evidence that approval would be denied.

Over days to weeks, expect headline-driven volatility and sensitivity to any committee or filing update. Over 1–3 months, the decisive catalysts are proposed consideration, independent fairness work, and credible protections for minority shareholders. Over 6–18 months, any realized benefit depends on measurable shared-project economics and transparent capital allocation. The contrarian point: merger synergy is being treated as strategic upside before terms exist; complexity and governance could instead reduce Tesla’s multiple. Thesis weakens if credible terms protect Tesla holders, approvals proceed without material delay, and management quantifies benefits without shifting disproportionate investment obligations to Tesla.

Key Decisions for Investors

• Avoid chasing the initial relative share move. Keep TSLA underweight versus SPCX as an event-risk stance only where mandates and liquidity permit; do not treat this as a clean fundamental pair trade before consideration terms and deal structure are known.
• Set an alert for the committee’s recommendation, exchange ratio or other consideration, fairness analysis, and any disclosure of veto or minority-holder protections. These are more decision-useful than general synergy claims.
• If a proposal emerges, model dilution and capital commitments separately for each shareholder group; verify whether Tesla-funded investment would support Tesla economics or subsidize projects elsewhere in the combined company.
• Reassess the governance discount if the process is delayed materially, terms appear asymmetric, or regulators raise national-security concerns. A credible independent process, balanced consideration, and quantified shared-project returns would challenge the underweight thesis.